Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2026-02-20 @ 12:43 AM
Study NCT ID:
NCT03624335
Status:
COMPLETED
Last Update Posted:
2018-08-10
First Post:
2018-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Influence of Umbilical Cord Clamping Time in the Newborn
Sponsor:
Pascual Gregori Roig
Organization:
Study Overview
Official Title:
Influence of Umbilical Cord Clamping Time in the Newborn, Secondary Neonatal Morbidity and Iron Deposits in the Neonate
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study compares two umbilical cord clamping times; the early one, up to a minute (ECC) and the late or delayed one, when the cord stop beating (DCC). The additional blood volume delivered to the newborn from the placenta - placental transference - by delaying umbilical cord ligation, increases the contribution of neonatal iron with increased iron stores in the infant, without increasing neonatal morbidity.
Detailed Description:
It is an intervention study without drugs administration with a longitudinal, prospective comparison and correlational design.
Patients are recruited by simple random sampling to one of the two intervention groups:
Group 1-ECC: Early clamping of the umbilical cord (before the first minute of life).
Group 2-DCC: Delayed clamping of the umbilical cord (when it stops beating).
Patients are recruited by simple random sampling to one of the two intervention groups:
Group 1-ECC: Early clamping of the umbilical cord (before the first minute of life).
Group 2-DCC: Delayed clamping of the umbilical cord (when it stops beating).
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: